Vitapharma Laboratory
SECTOR
Pharmaceutical
TARGET COMPANY
Vitapharma Laboratory
INVESTORS
Calox International
SELLERS
Vitapharma Laboratory
SHARE SOLD
Majority share package %
AÑO DE TRANSACCIÓN
2024
About the investor
Vitapharma is a leading Peruvian company with more than 15 years of experience in the manufacturing and marketing of high-quality pharmaceutical products. Its portfolio includes treatments for cardiovascular diseases, digestive disorders, dermatological conditions and other medical specialties. The company has modern facilities in Lurín, Lima, where it develops and produces medicines in various presentations, such as tablets, capsules, syrups and creams.
Transaction summary
UNE Asesores Financieros provided comprehensive advice to Vitapharma on the sale of a majority stake in its shares to the Venezuelan pharmaceutical group Calox International, facilitating the latter's entry into the Peruvian market. This transaction is part of Calox International's expansion strategy in the Andean region, which includes countries such as Colombia, Ecuador and Peru. With this acquisition, Calox International seeks to strengthen its presence in the Peruvian market and expand its capacity to produce and distribute medicines in the region.
